Advancement of metal compounds as therapeutic and diagnostic metallodrugs: Current frontiers and future perspectives
Coordination compounds on account of distinctive features of metal ions that include
variable oxidation states, diverse range of geometries and coordination numbers …
variable oxidation states, diverse range of geometries and coordination numbers …
[HTML][HTML] Prospective of 68Ga-radiopharmaceutical development
I Velikyan - Theranostics, 2014 - ncbi.nlm.nih.gov
Abstract Positron Emission Tomography (PET) experienced accelerated development and
has become an established method for medical research and clinical routine diagnostics on …
has become an established method for medical research and clinical routine diagnostics on …
68Ga-Based Radiopharmaceuticals: Production and Application Relationship
I Velikyan - Molecules, 2015 - mdpi.com
The contribution of 68Ga to the promotion and expansion of clinical research and routine
positron emission tomography (PET) for earlier better diagnostics and individualized …
positron emission tomography (PET) for earlier better diagnostics and individualized …
In vivo targeting and positron emission tomography imaging of tumor vasculature with 66Ga-labeled nano-graphene
The goal of this study was to employ nano-graphene for tumor targeting in an animal tumor
model, and quantitatively evaluate the pharmacokinetics and tumor targeting efficacy …
model, and quantitatively evaluate the pharmacokinetics and tumor targeting efficacy …
Quantitative and qualitative intrapatient comparison of 68Ga-DOTATOC and 68Ga-DOTATATE: net uptake rate for accurate quantification
I Velikyan, A Sundin, J Sörensen… - Journal of Nuclear …, 2014 - Soc Nuclear Med
Quantitative imaging and dosimetry are crucial for individualized treatment during peptide
receptor radionuclide therapy (PRRT). 177Lu-DOTATATE and 68Ga-DOTATOC/68Ga …
receptor radionuclide therapy (PRRT). 177Lu-DOTATATE and 68Ga-DOTATOC/68Ga …
Cold Kit Labeling: The Future of 68Ga Radiopharmaceuticals?
N Lepareur - Frontiers in Medicine, 2022 - frontiersin.org
Over the last couple of decades, gallium-68 (68Ga) has gained a formidable interest for PET
molecular imaging of various conditions, from cancer to infection, through cardiac …
molecular imaging of various conditions, from cancer to infection, through cardiac …
Emerging protein targets for metal-based pharmaceutical agents: An update
A De Almeida, BL Oliveira, JDG Correia… - Coordination Chemistry …, 2013 - Elsevier
The peculiar chemical properties of metal-based drugs impart innovative pharmacological
profiles to this class of therapeutic and diagnostic agents, most likely in relation to novel …
profiles to this class of therapeutic and diagnostic agents, most likely in relation to novel …
Gallium-68 in medical imaging
L Martiniova, LD Palatis, E Etchebehere… - Current …, 2016 - ingentaconnect.com
Over the past several years, Positron Emission Tomography (PET) imaging agents labeled
with 68Gallium (68Ga) have undergone a significant increase in clinical utilization. 68Ga is …
with 68Gallium (68Ga) have undergone a significant increase in clinical utilization. 68Ga is …
Recent Breakthrough in 68Ga-Radiopharmaceuticals Cold Kits for Convenient PET Radiopharmacy
D Satpati - Bioconjugate Chemistry, 2021 - ACS Publications
68Ga-PET has emerged as an important diagnostic tool for precise detection and monitoring
of oncological situations. Availability, cost, and radiosynthesis procedure are determining …
of oncological situations. Availability, cost, and radiosynthesis procedure are determining …
Gallium (III) complexes of NOTA‐bis (phosphonate) conjugates as PET radiotracers for bone imaging
J Holub, M Meckel, V Kubíček, F Rösch… - Contrast Media & …, 2015 - Wiley Online Library
Ligands with geminal bis (phosphonic acid) appended to 1, 4, 7‐triazacyclonone‐1, 4‐
diacetic acid fragment through acetamide (NOTAMBP) or methylenephosphinate …
diacetic acid fragment through acetamide (NOTAMBP) or methylenephosphinate …